Author response for "Safety and tolerability of semaglutide across the <scp>SUSTAIN</scp> and <scp>PIONEER</scp> phase <scp>IIIa</scp> clinical trial programmes"
crossref（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要